SAN JOSE, Calif.
- Sept. 18, 2020
-- San Jose, CA, September 10, 2020: OptraHEALTH®
, a leading data-driven intelligence company today announced that the United States Patent and Trademark Office(USPTO)
has granted the patent to OptraHEALTH for healthcare AI applications with machine assisted process for health information handling.
has patented this invention which covers health information handling through the reporting system via the query-interrogation system. The knowledge-graphing system, which is generated using artificial intelligence modules, natural language understanding modules, and machine learning modules, is utilized to provide accurate information to the users. An administrative system monitors the validity of health information from these reporting systems.
"It's a wonderful feeling to get the patent that describes our uniqueness in the AI-powered ChatBOT innovations for Healthcare Industry. With Patent and market leadership, we are now looking forward to making a significant impact in the healthcare market with the mission to augment the various processes in the healthcare and life science industry with intelligent, machine-assisted systems" said Dr. Gauri Naik, Co-Founder & CEO, OptraHEALTH, Inc. About OptraHEALTH®:
is focused on improving outcomes for consumers and leading Life Sciences and Healthcare organizations by utilizing our next-generation Artificial Intelligence Platform. OptraHEALTH's flagship product GeneFAX™ is an AI-powered Knowledge Platform for Genetic Health and is available as a Web Plugin or Mobile application. Follow us on LinkedIn and Twitter.
Media Inquiries Contact:
Dr. Ashwin Kotwaliwale | Product Manager | OptraHEALTH, Inc | firstname.lastname@example.org
Katie Roberts | Business Analyst | OptraHEALTH, Inc | email@example.com